Elonox and Elonox HP (enoxaparin sodium)

pCPA File Number: 21904

Negotiation Status:

Concluded with an LOI

Indication(s):

Prevention or treatment of thrombosis and cardiovascular conditions

Sponsor/Manufacturer:

Fresenius Kabi Canada Ltd.

CADTH Project Number:

Not Applicable

pCPA Engagement Letter Issued:

2022-09-13

Negotiation Process Concluded:

2023-01-09